Cellectar Biosciences, Inc. (CLRB) vs Ensysce Biosciences, Inc. (ENSC)
- Cellectar Biosciences, Inc. CLRB 1.14 −4.20%
- Ensysce Biosciences, Inc. ENSC 0.52 −13.33%
Cellectar Biosciences, Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Ensysce Biosciences, Inc. are of similar size ($11.6M and $11.2M). Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Cellectar Biosciences, Inc. leads on 8 and Ensysce Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | CLRB | ENSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (281.32%) | 0.00% |
| Net margin | 0.00% | (280.49%) | 0.00% |
| Free cash flow margin | 0.00% | (196.76%) | 0.00% |
| Return on equity | (125.99%) | (1,295.01%) | (56.36%) |
| Return on assets | (88.70%) | (295.92%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack